Citations (63)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Thomas Wilke, Burkhard Weisser, Hans-Georg Predel, Roland Schmieder, Sven Wassmann, Anton Gillessen, Jörg Blettenberg, Ulf Maywald, Olaf Randerath, Sabrina Mueller & Michael Böhm. (2022) Effects of Single Pill Combinations Compared to Identical Multi Pill Therapy on Outcomes in Hypertension, Dyslipidemia and Secondary Cardiovascular Prevention: The START-Study. Integrated Blood Pressure Control 15, pages 11-21.
Read now
Read now
Ildiko Lingvay, Nadine Beetz, Regina Sennewald, Annette Schuler-Metz, Julia Bertulis, Christina Loley, Benjamin Lang, Caroline Lippert, Jisoo Lee, Linda Shapiro Manning & Derek Terada. (2020) Triple fixed-dose combination empagliflozin, linagliptin, and metformin for patients with type 2 diabetes. Postgraduate Medicine 132:4, pages 337-345.
Read now
Read now
Adel Mohamed Kamal El-Etriby & Sameh Rakha. (2020) Efficacy and safety of amlodipine/valsartan/hydrochlorothiazide single pill combination in Egyptian patients with hypertension uncontrolled on any dual therapy: an observational study. Current Medical Research and Opinion 36:4, pages 537-544.
Read now
Read now
Jaejin An, Janet S. Lee, Lucie Sharpsten, Annikka K. Wilson, Feng Cao & Josephine N. Tran. (2019) Impact of pill burden on adherence to hepatitis C medication. Current Medical Research and Opinion 35:11, pages 1937-1944.
Read now
Read now
Michael Bogart, Richard H Stanford, François Laliberté, Guillaume Germain, Jennifer W Wu & Mei Sheng Duh. (2019) Medication adherence and persistence in chronic obstructive pulmonary disease patients receiving triple therapy in a USA commercially insured population. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 343-352.
Read now
Read now
Louise E Bartlett, Nicole L Pratt & Elizabeth E Roughead. (2018) Prior experience with cardiovascular medicines predicted longer persistence in people initiated to combinations of antihypertensive and lipid-lowering therapies: findings from two Australian cohorts. Patient Preference and Adherence 12, pages 835-843.
Read now
Read now
Hiromi Rakugi, Kohei Shimizu, Yuya Nishiyama, Yuhei Sano & Yuusuke Umeda. (2018) A phase III, open-label, multicenter study to evaluate the safety and efficacy of long-term triple combination therapy with azilsartan, amlodipine, and hydrochlorothiazide in patients with essential hypertension. Blood Pressure 27:3, pages 125-133.
Read now
Read now
Louise E. Bartlett, Nicole Pratt & Elizabeth E. Roughead. (2018) Does a fixed-dose combination of amlodipine and atorvastatin improve persistence with therapy in the Australian population?. Current Medical Research and Opinion 34:2, pages 305-311.
Read now
Read now
Stewart B. Harris. (2016) The power of two: an update on fixed-dose combinations for type 2 diabetes. Expert Review of Clinical Pharmacology 9:11, pages 1453-1462.
Read now
Read now
Srinivas Nalamachu, Ernest A. Kopecky, Robert Taylor Jr, Ben Vaughn & Melinda O’Connor. (2016) Evaluation of the durability of pain relief throughout a 12 hour dosing interval of a novel, extended-release, abuse-deterrent formulation of oxycodone. Current Medical Research and Opinion 32:7, pages 1311-1317.
Read now
Read now
Articles from other publishers (53)
Hala Yamout & George L. Bakris. 2024. Hypertension. Hypertension
304
309
.
G. Mancia, F. P. Cappuccio, M. Burnier, A. Coca, A. Persu, C. Borghi, R. Kreutz & B. Sanner. (2023) Perspectives on improving blood pressure control to reduce the clinical and economic burden of hypertension. Journal of Internal Medicine 294:3, pages 251-268.
Crossref
Crossref
Federico Rea, Gabriella Morabito, Laura Savaré, Atul Pathak, Giovanni Corrao & Giuseppe Mancia. (2023) Adherence and related cardiovascular outcomes to single pill vs. separate pill administration of antihypertensive triple-combination therapy. Journal of Hypertension 41:9, pages 1466-1473.
Crossref
Crossref
Eva Kociánová, Miloš Táborský & Jan Václavik. (2023) A practical approach to assessment of non-adherence to antihypertensive treatment. Journal of Hypertension 41:9, pages 1371-1375.
Crossref
Crossref
Qiran Wei, Jiting Zhou, Hongchao Li, Luying Wang, Yao Wu, Aixia Ma & Xin Guan. (2023) Medication adherence with fixed-dose versus free-equivalent combination therapies: Systematic review and meta-analysis. Frontiers in Pharmacology 14.
Crossref
Crossref
William W. Busse, Carl B. Abbott, Guillaume Germain, François Laliberté, Sean D. MacKnight, Young Jung, Mei Sheng Duh & Carlyne M. Averell. (2022) Adherence and Persistence to Single-Inhaler Versus Multiple-Inhaler Triple Therapy for Asthma Management. The Journal of Allergy and Clinical Immunology: In Practice 10:11, pages 2904-2913.e6.
Crossref
Crossref
R. Paranjpe, M. L. Johnson, H. Chen, K. Birtcher, O. Serna, A. Mohan & Susan Abughosh. (2022) Evaluating Adherence to Concomitant Diabetes, Hypertension, and Hyperlipidemia Treatments and Cardiovascular Outcomes Among Elderly Patients Using Marginal Structural Modeling. High Blood Pressure & Cardiovascular Prevention 29:6, pages 601-610.
Crossref
Crossref
Luis Michea, Luis Toro, Natali Alban, Daisy Contreras, Patricia Morgado, Melanie Paccot, Maria Cristina Escobar & Eduardo Lorca. (2022) Eficacia de una estrategia estandarizada y simplificada para tratamiento de la hipertensión arterial en Chile: la Iniciativa HEARTS en las Américas. Revista Panamericana de Salud Pública 46, pages 1.
Crossref
Crossref
Rutugandha Paranjpe, Hua Chen, Michael L. Johnson, Kim Birtcher, Omar Serna & Susan Abughosh. (2022) Adherence to concomitant diabetes, hypertension, and hyperlipidemia treatments among older patients. Journal of the American Pharmacists Association 62:4, pages 1351-1358.
Crossref
Crossref
Rutugandha Paranjpe, Michael L. Johnson, Hua Chen, Kim Birtcher, Omar Serna, Anjana Mohan & Susan Abughosh. (2022) Evaluating adherence to concomitant diabetes, hypertension, and hyperlipidemia treatments and intermediate outcomes among elderly patients using marginal structural modeling. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 42:7, pages 518-528.
Crossref
Crossref
Armand Mbanya, Azarkhan Ackbarkhan, Mohammad Yaseen Mittoo, Haja Andriamiadanarivo Ramamonjisoa, Benja Ramilitiana, Eliane Mikkelsen Ranivoharisoa, Solohery Jean Noël Ratsimbazafy & Jean Claude Mbanya. (2022) Use of Perindopril Arginine/Indapamide/Amlodipine in the Management of Hypertension in Two Sub-Saharan African Island Countries of Madagascar and Mauritius. Advances in Therapy 39:6, pages 2850-2861.
Crossref
Crossref
AnisA'lliya Abdul Latif, KaiWei Lee, Kelly Phang, AneesaAbdul Rashid, NeeNee Chan, SuatCheng Peh, Thiruventhiran Thilaganathan & PeiBoon Ooi. (2022) Patient-related factors associated with medication adherence behavior in patients with end-stage renal disease: A systematic review. Tzu Chi Medical Journal 34:4, pages 473.
Crossref
Crossref
Jieun Lee, Jaeyun Choi, Yunjin Yum, Hyung Joon Joo, Yong‐Hyun Kim, Hyonggin An & Eung Ju Kim. (2021) Clinical effectiveness and safety of amlodipine/losartan‐based single‐pill combination therapy in patients with hypertension: Findings from real‐world, multicenter observational databases. The Journal of Clinical Hypertension 23:11, pages 1975-1983.
Crossref
Crossref
Yanglong Li, Megumi Narisawa, Zhe Huang, Xiangkunm Meng, Hailong Wang, Xueying Jin, Xionghu Shen & Xian Wu Cheng. (2021) Expanding role for single‐pill combination drug therapy in the initial treatment of hypertension?. The Journal of Clinical Hypertension 23:11, pages 1984-1986.
Crossref
Crossref
Renata Pinhati, Renato Ferreira, Moisés Carminatti, Fernando Colugnati, Rogério de Paula & Helady Sanders‐Pinheiro. (2020) Adherence to antihypertensive medication after referral to secondary healthcare: A prospective cohort study. International Journal of Clinical Practice 75:3.
Crossref
Crossref
LT Sean Navin. (2019) Blister Packaging Medications for Adherence for American Indians/Alaska Natives in the Outpatient Setting. Journal of Pharmacy Practice 34:1, pages 97-102.
Crossref
Crossref
Gianfranco Parati, Sverre Kjeldsen, Antonio CocaWilliam C. Cushman & Jiguang Wang. (2021) Adherence to Single-Pill Versus Free-Equivalent Combination Therapy in Hypertension. Hypertension 77:2, pages 692-705.
Crossref
Crossref
Agnes Bosch & Roland E. Schmieder. (2021) Novel approaches to management of hypertension. Current Opinion in Nephrology & Hypertension 30:1, pages 54-62.
Crossref
Crossref
Yu. A. Karpov, V. M. Gorbunov & N. A. Logunova. (2020) Triple fixed-dose combination in the treatment of hypertension: the results of the Russian observational study TRICOLOR. Russian Journal of Cardiology 25:10, pages 4130.
Crossref
Crossref
Konstantinos Tsioufis, Reinhold Kreutz, Georgia Sykara, Joris van Vugt & Tarek Hassan. (2020) Impact of single-pill combination therapy on adherence, blood pressure control, and clinical outcomes: a rapid evidence assessment of recent literature. Journal of Hypertension 38:6, pages 1016-1028.
Crossref
Crossref
Niccolò Lombardi, Giada Crescioli, Monica Simonetti, Ettore Marconi, Alfredo Vannacci, Alessandra Bettiol, Damiano Parretti, Claudio Cricelli & Francesco Lapi. (2020) Adherence to Triple-Free-Drug Combination Therapies Among Patients With Cardiovascular Disease. The American Journal of Cardiology 125:9, pages 1429-1435.
Crossref
Crossref
Neil R. Poulter, Claudio Borghi, Gianfranco Parati, Atul Pathak, Diana Toli, Bryan Williams & Roland E. Schmieder. (2020) Medication adherence in hypertension. Journal of Hypertension 38:4, pages 579-587.
Crossref
Crossref
Burkhard Weisser, Hans-Georg Predel, Anton Gillessen, Claudia Hacke, Johannes vor dem Esche, Gerd Rippin, Andrea Noetel & Olaf Randerath. (2020) Single Pill Regimen Leads to Better Adherence and Clinical Outcome in Daily Practice in Patients Suffering from Hypertension and/or Dyslipidemia: Results of a Meta-Analysis. High Blood Pressure & Cardiovascular Prevention 27:2, pages 157-164.
Crossref
Crossref
Ana Baumgartner, Katarina Drame, Stijn Geutjens & Marja Airaksinen. (2020) Does the Polypill Improve Patient Adherence Compared to Its Individual Formulations? A Systematic Review. Pharmaceutics 12:2, pages 190.
Crossref
Crossref
Burkay YAKAR, Asli AZAKOGLU KARACA & Erhan ONALAN. (2019) Assessment of adherence to drug treatment and affecting factors among hypertensive patientsHipertansif hastalarda ilaç tedavisine uyum ve etkileyen faktörlerin değerlendirilmesi. Family Practice and Palliative Care 4:3, pages 89-95.
Crossref
Crossref
N R Gizi Azayeva. (2019) Clinical-hemodynamic efficiency of fixed combined hypotensin therapy for patients with heavy arterial hypertension. Bulletin of the Russian Military Medical Academy 21:2, pages 48-51.
Crossref
Crossref
Tiffany E. ChangMatthew D. RitcheySoyoun ParkAnping ChangErika C. OdomJeffrey DurthalerSandra L. JacksonFleetwood Loustalot. (2019) National Rates of Nonadherence to Antihypertensive Medications Among Insured Adults With Hypertension, 2015. Hypertension 74:6, pages 1324-1332.
Crossref
Crossref
Anna Vachulová. (2019) The myths and facts about arterial hypertension: do we really know everything about arterial hypertension?. Vnitřní lékařství 65:11, pages 728-733.
Crossref
Crossref
Massimo Leggio, Augusto Fusco, Claudia Loreti, Giorgio Limongelli, Maria Grazia Bendini, Andrea Mazza, Antonio Frizziero, Daniele Coraci & Luca Padua. (2019) Fixed and Low-Dose Combinations of Blood Pressure-Lowering Agents: For the Many or the Few?. Drugs 79:17, pages 1831-1837.
Crossref
Crossref
Heinz Gisslinger, Veronika Buxhofer‐Ausch, Juri Hodisch, Atanas Radinoff, Elena Karyagina, Slawomira Kyrcz‐Krzemień, Kudrat Abdulkadyrov, Rolandas Gerbutavicius, Anait Melikyan, Sonja Burgstaller, Marek Hus, Janusz Kłoczko, Vera Yablokova, Nikolay Tzvetkov, Malgorzata Całbecka, Tatyana Shneyder, Krzysztof Warzocha, Mindaugas Jurgutis, Kamil Kaplanov, Bernd Jilma, Christian Schoergenhofer & Christoph Klade. (2019)
A phase
III
randomized, multicentre, double blind, active controlled trial to compare the efficacy and safety of two different anagrelide formulations in patients with essential thrombocythaemia – the
TEAM
‐
ET
2·0 trial
. British Journal of Haematology 185:4, pages 691-700.
Crossref
Crossref
Priti P. Pednekar, Tamás Ágh, Maria Malmenäs, Amit D. Raval, Bryan M. Bennett, Bijan J. Borah, David S. Hutchins, Elizabeth Manias, Allison F. Williams, Mickaël Hiligsmann, Adina Turcu-Stiolica, John E. Zeber, Lusine Abrahamyan, Thomas J. Bunz & Andrew M. Peterson. (2019) Methods for Measuring Multiple Medication Adherence: A Systematic Review–Report of the ISPOR Medication Adherence and Persistence Special Interest Group. Value in Health 22:2, pages 139-156.
Crossref
Crossref
Brent M. Egan, Susan E. Sutherland, Michael RakotzJianing YangR. Bruce Hanlin, Robert A. Davis & Gregory Wozniak. (2018) Improving Hypertension Control in Primary Care With the Measure Accurately, Act Rapidly, and Partner With Patients Protocol. Hypertension 72:6, pages 1320-1327.
Crossref
Crossref
Stelina Alkagiet & Konstantinos Tziomalos. (2018) Suboptimal Adherence to Antihypertensive Treatment: Causes and Management. The Open Hypertension Journal 10:1, pages 41-45.
Crossref
Crossref
Mathilde Lefort, Lola Neufcourt, Bruno Pannier, Bernard Vaïsse, Sahar Bayat, Olivier Grimaud & Xavier Girerd. (2018) Sex differences in adherence to antihypertensive treatment in patients aged above 55: The French League Against Hypertension Survey (FLAHS). The Journal of Clinical Hypertension 20:10, pages 1496-1503.
Crossref
Crossref
Li‐Ping Du, Zhong‐Wei Cheng, Yu‐Xuan Zhang, Ying Li & Dan Mei. (2018) The impact of fixed‐dose combination versus free‐equivalent combination therapies on adherence for hypertension: a meta‐analysis. The Journal of Clinical Hypertension 20:5, pages 902-907.
Crossref
Crossref
Peter Bramlage, Stefanie Schmidt & Helen Sims. (2018) Fixed‐dose vs free‐dose combinations for the management of hypertension—An analysis of 81 958 patients. The Journal of Clinical Hypertension 20:4, pages 705-715.
Crossref
Crossref
Robert B. Hanlin, Irfan M. Asif, Gregory Wozniak, Susan E. Sutherland, Bijal Shah, Jianing Yang, Robert A. Davis, Sean T. Bryan, Michael Rakotz & Brent M. Egan. (2018) Measure Accurately, Act Rapidly, and Partner With Patients (MAP) improves hypertension control in medically underserved patients: Care Coordination Institute and American Medical Association Hypertension Control Project Pilot Study results. The Journal of Clinical Hypertension 20:1, pages 79-87.
Crossref
Crossref
Hala Yamout & George L. Bakris. 2018. Hypertension: A Companion to Braunwald's Heart Disease. Hypertension: A Companion to Braunwald's Heart Disease
261
267
.
Katherine A. Lyseng-Williamson. (2017) Olmesartan medoxomil/amlodipine/hydrochlorothiazide 20 mg/5 mg/12.5 mg fixed-dose combination in hypertension: a profile of its use. Drugs & Therapy Perspectives 34:1, pages 1-7.
Crossref
Crossref
Idir Hamdidouche, Vincent Jullien, Stéphane Laurent & Michel Azizi. 2018. Drug Adherence in Hypertension and Cardiovascular Protection. Drug Adherence in Hypertension and Cardiovascular Protection
185
197
.
Andrea L. Schaffer, Nicholas A. Buckley & Sallie-Anne Pearson. (2017) Who benefits from fixed-dose combinations? Two-year statin adherence trajectories in initiators of combined amlodipine/atorvastatin therapy. Pharmacoepidemiology and Drug Safety 26:12, pages 1465-1473.
Crossref
Crossref
Eva Račická. (2017) Fixed-dose combinations - therapy of type 2 diabetes mellitus. Interní medicína pro praxi 19:4, pages 186-190.
Crossref
Crossref
D M van der Laan, P J M Elders, C C L M Boons, J J Beckeringh, G Nijpels & J G Hugtenburg. (2017) Factors associated with antihypertensive medication non-adherence: a systematic review. Journal of Human Hypertension 31:11, pages 687-694.
Crossref
Crossref
Francesco Vittorio Costa. (2017) Improving Adherence to Treatment and Reducing Economic Costs of Hypertension: The Role of Olmesartan-Based Treatment. High Blood Pressure & Cardiovascular Prevention 24:3, pages 265-274.
Crossref
Crossref
Jean-Jacques Mourad, Celso Amodeo, Martine de Champvallins, Romualda Brzozowska-Villatte & Roland Asmar. (2017) Blood pressure-lowering efficacy and safety of perindopril/indapamide/amlodipine single-pill combination in patients with uncontrolled essential hypertension. Journal of Hypertension 35:7, pages 1481-1495.
Crossref
Crossref
Alberto Mazza, Salvatore Lenti, Laura Schiavon, Antonella Paola Sacco, Fabio Dell’Avvocata, Gianluca Rigatelli & Emilio Ramazzina. (2017) Fixed-Dose Triple Combination of Antihypertensive Drugs Improves Blood Pressure Control: From Clinical Trials to Clinical Practice. Advances in Therapy 34:4, pages 975-985.
Crossref
Crossref
Louise E. Bartlett, Nicole Pratt & Elizabeth E. Roughead. (2017) Does tablet formulation alone improve adherence and persistence: a comparison of ezetimibe fixed dose combination versus ezetimibe separate pill combination?. British Journal of Clinical Pharmacology 83:1, pages 202-210.
Crossref
Crossref
Yasser M. Alatawi, Jan Kavookjian, Gladys Ekong & Meshari M. Alrayees. (2016) The association between health beliefs and medication adherence among patients with type 2 diabetes. Research in Social and Administrative Pharmacy 12:6, pages 914-925.
Crossref
Crossref
Muhammad Ali Sheraz, Syed Furqan Ahsan, Marium Fatima Khan, Sofia Ahmed & Iqbal Ahmad. (2016) Formulations of Amlodipine: A Review. Journal of Pharmaceutics 2016, pages 1-11.
Crossref
Crossref
Joseph V. PergolizziJrJr, Robert B. Raffa, Gianpietro Zampogna, Frank Breve, Robert Colucci, William K. Schmidt & Jo Ann LeQuang. (2016)
Comments and Suggestions from Pain Specialists Regarding the
CDC
's Proposed Opioid Guidelines
. Pain Practice 16:7, pages 794-808.
Crossref
Crossref
Katherine A. Lyseng-Williamson. (2016) Olmesartan medoxomil: a guide to its use as monotherapy or in fixed-dose combinations with amlodipine and/or hydrochlorothiazide. Drugs & Therapy Perspectives 32:9, pages 369-380.
Crossref
Crossref
Carlos Aguiar. (2015) Patient Cases 2. A Patient with Apparent Resistant Hypertension. High Blood Pressure & Cardiovascular Prevention 22:S1, pages 19-22.
Crossref
Crossref
Michael Hubert. (2015) Fixkombinationen verbessern die Compliance. MMW - Fortschritte der Medizin 157:6, pages 70-70.
Crossref
Crossref